Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-002037
Filing Date
2025-01-21
Accepted
2025-01-21 16:38:57
Documents
2
Period of Report
2025-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1737495531.html 4  
1 FORM 4 wk-form4_1737495531.xml 4 3267
2 EX-24 halladaypoa.htm EX-24 13141
  Complete submission text file 0001628280-25-002037.txt   17974
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Halladay Benjamin (Reporting) CIK: 0001953943 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 25542995